Clinical Diagnostics

Comprehensive Clinical Test Catalogue

Advanced Diagnostic Solutions for Precision Medicine

NABL-accredited laboratory offering 93 specialized diagnostic tests across 11 clinical specialties. From prenatal genetics to infectious disease detection, we provide accurate, timely results that guide critical healthcare decisions.

93
Diagnostic Tests
11
Specialties
NABL
Accredited
Clinical Laboratory

Rare Disease Panels

Disease-specific next-generation sequencing panels across cardiology, nephrology, immunology, and 10+ rare genetic disease categories.

MDB-RD-001

Medio Cardiology Panel

Comprehensive gene panel for inherited cardiac disorders, including cardiomyopathies, channelopathies, and arrhythmia syndromes.

MethodologyTargeted NGS panel
SampleBlood EDTA
TAT25 Days
MDB-RD-002

Medio Skin Panel

Focused gene panel for inherited dermatological and keratinization disorders such as ichthyosis, epidermolysis bullosa, and ectodermal dysplasia.

MethodologyTargeted NGS panel
SampleBlood EDTA
TAT25 Days
MDB-RD-003

Medio Dysmorphia Panel

Genetic panel designed for syndromic and non-syndromic developmental anomalies associated with craniofacial dysmorphism and structural malformations.

MethodologyTargeted NGS panel
SampleBlood EDTA
TAT25 Days
MDB-RD-004

Medio Connective Tissue Panel

Comprehensive panel assessing genes linked to connective tissue and collagen disorders such as Ehlers-Danlos, Marfan, and Loeys-Dietz syndromes.

MethodologyTargeted NGS panel
SampleBlood EDTA
TAT25 Days
MDB-RD-005

Medio Hearing Panel

Gene panel for congenital and progressive hearing loss, covering both syndromic and non-syndromic deafness-related genes.

MethodologyTargeted NGS panel
SampleBlood EDTA
TAT25 Days
MDB-RD-006

Medio Diabetes Panel

Focused panel for monogenic and syndromic forms of diabetes, including MODY, neonatal diabetes, and mitochondrial-linked diabetes.

MethodologyTargeted NGS panel
SampleBlood EDTA
TAT25 Days
MDB-RD-007

Medio Blood Coagulation Panel

Targeted panel for inherited thrombophilia and bleeding disorders, including hemophilia, von Willebrand disease, and platelet function defects.

MethodologyTargeted NGS panel
SampleBlood EDTA
TAT25 Days
MDB-RD-008

Medio Anemia Panel

Comprehensive panel for inherited anemias and hemoglobinopathies such as thalassemia, sickle-cell disease, and sideroblastic anemia.

MethodologyTargeted NGS panel
SampleBlood EDTA
TAT25 Days
MDB-RD-009

Medio Immune Panel

Gene panel for primary immunodeficiency and autoinflammatory disorders affecting adaptive and innate immune pathways.

MethodologyTargeted NGS panel
SampleBlood EDTA
TAT25 Days
MDB-RD-010

Medio IEM Panel

Extensive panel for inborn errors of metabolism, including amino acid, organic acid, and fatty acid oxidation disorders.

MethodologyTargeted NGS panel
SampleBlood EDTA
TAT25 Days
MDB-RD-011

Medio Mitochondria Panel

Targeted panel for mitochondrial and energy metabolism disorders involving both nuclear and mitochondrial genes.

MethodologyTargeted NGS panel
SampleBlood EDTA
TAT25 Days
MDB-RD-012

Medio Nephrology Panel

Comprehensive panel for inherited kidney diseases such as nephrotic syndrome, polycystic kidney disease, and tubulopathies.

MethodologyTargeted NGS panel
SampleBlood EDTA
TAT25 Days
MDB-RD-013

Medio Vision Panel

Focused panel for inherited retinal and optic nerve disorders, including retinitis pigmentosa, Leber congenital amaurosis, and cone-rod dystrophy.

MethodologyTargeted NGS panel
SampleBlood EDTA
TAT25 Days
MDB-RD-014

Medio Bone Panel

Comprehensive panel for skeletal dysplasias, bone fragility disorders, and abnormalities in bone mineralization and growth.

MethodologyTargeted NGS panel
SampleBlood EDTA
TAT25 Days
MDB-RD-015

Medio Pulmonary Panel

Focused gene panel for inherited lung disorders, including surfactant dysfunction, primary ciliary dyskinesia, and interstitial lung disease.

MethodologyTargeted NGS panel
SampleBlood EDTA
TAT25 Days
MDB-RD-016

Medio Pancreatitis Panel

Targeted gene panel for hereditary and idiopathic forms of recurrent and chronic pancreatitis involving pancreatic enzyme regulation pathways.

MethodologyTargeted NGS panel
SampleBlood EDTA
TAT25 Days
MDB-WS-001

Whole Exome Sequencing

Comprehensive sequencing of all protein-coding regions (exons) of the genome to identify pathogenic, likely pathogenic, and clinically relevant variants associated with monogenic and complex disorders across multiple organ systems.

MethodologyWhole Exome Sequencing (WES) by targeted exon capture and NGS
SampleBlood EDTA
TAT25 Days